Nicole Bézay

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl et al. · The Lancet Infectious Diseases · 2020 · 98 citations

Vaccination, Vaccine Safety, Vaccinology +7

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers

Nicole Bézay, Andrea Ayad, Katrin Dubischar et al. · Vaccine · 2016 · 82 citations

Vaccination, Vaccine Development, Healthy Volunteers +9

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

Nicole Bézay, Romana Hochreiter, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2023 · 37 citations

Vaccination, Vaccine Development, Vaccine Research +9

Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies

Nicole Bézay, Laura Danielle Wagner, Vera Kadlecek et al. · The Lancet Infectious Diseases · 2024 · 25 citations

Vaccination, Vaccine Safety, Dose Level +8

Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial

Santhosh Kumar Ghadge, Martina Schneider, Katrin Dubischar et al. · The Lancet Infectious Diseases · 2024 · 12 citations